Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Central Nervous System Tumors
  •  Surgical Oncology
  •  Head and Neck Oncology
  •  Bladder Cancer
  •  Chemoprevention
  •  General Oncology
  •  Adjuvant Therapy
  •  Stomach Cancer

Abstract

Citation: Clin Oncol. 2017;2(1):1218.DOI: 10.25107/2474-1663.1218

Choline PET/CT Imaging for Management of Prostate Cancer

Kazuhiro Kitajima, Kazuhito Fukushima, Koichiro Yamakado, Shozo Hirota and Shingo Yamamoto

Department of Radiology, Division of Nuclear Medicine and PET Center, Hyogo College of Medicine, Japan
Department of Radiology, Hyogo College of Medicine, Japan
Department of Urology, Hyogo College of Medicine, Japan

*Correspondance to: Kazuhiro Kitajima 

 PDF  Full Text Mini Review | Open Access

Abstract:

Whole-body Positron Emission Tomography/Computed Tomography (PET/CT) with [11C]- and [18F]-labeled choline derivatives has emerged as a promising molecular imaging modality for evaluation of prostate cancer. 11C-choline and 18F-flurocholine PET/CT examinations have been shown to be effective for restaging of prostate cancer patients with biochemical disease recurrence after undergoing definitive therapy, especially those with a serum prostate-specific antigen level >1.0 ng/mL. On the other hand, they have more limited roles for initial staging of prostate cancer or detection of tiny lymph node metastasis, due to the low spatial resolution inherent with PET. Overall, these modalities are most useful for cases with a high pre-test suspicion of metastatic disease. Here, we review the current clinical roles of 11C-choline and 18F-fluorocholine PET/CT for management of patients with prostate cancer.

Keywords:

prostate cancer; Staging; Restaging; 11C-choline; 18F-fluorocholine; Positron emission tomography/computed tomography (PET/CT)

Cite the Article:

Kitajima K, Fukushima K, Yamakado K, Hirota S, Yamamoto S. Choline PET/CT Imaging for Management of Prostate Cancer. Clin Oncol. 2017; 2: 1218.

Search Our Journal

Journal Indexed In

Articles in PubMed

NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Detection of Tumor-Related Biomarkers in Hepatocellular Carcinoma Patients by Sequencing Circulating Cell-Free DNA
 Abstract  PDF  Full Text
A Genetic Predictive Model for Precision Treatment of Diffuse Large B-Cell Lymphoma with Early Progression
 Abstract  PDF  Full Text
View More...